b>A Diagnostics & Imaging Week
University Hospitals Case Medical Center (UHCMC; Cleveland, Illinois) and Cardialysis BV (The Netherlands) reported that the companies have the intention to found Cardialysis Cleveland to provide combined clinical drug development and medical imaging services to clients that are developing therapeutics or medical devices for cardiovascular indications in world wide studies.
Cardialysis is a full service Academic Contract Research Organization and a provider of imaging core laboratory and clinical event adjudication services for studies in cardiac device and other cardiovascular indications. Cardialysis provides centralized expert evaluations of medical images from multi-modality environments including angiography, IVUS (intra vascular ultrasound) and IVUS related techniques (such as virtual histology and palpography), OCT, MRI, MSCT (multi slicecomputer tomography), ECHO and PV-loop.
The collaboration will focus on founding Cardialysis-Cleveland, a core lab with globally standardized Code Federal Regulations chapter 21 part 11 compliant technologies enabling global large-scale trials and registries in the coronary and peripheral vascular devices as well as in drug trials. The combined expertise of the companies will provide clients with an integrated team dedicated to clinical development and biomedical imaging and streamline project and data management processes.
"The combination of University Hospitals Case Medical Center's cutting-edge translational research and biotechnology and Cardialysis' expertise in cardiovascular imaging will benefit clients today and in the future as new techniques improve our ability to study cardiovascular diseases," commented Dr. Daniel Simon, Director, Heart & Vascular Institute, and Herman K. Hellerstein Professor of Medicine. "We look forward to leveraging the strong academic collaboration between Professor Serruys, Erasmus MC, Professor Costa, CWRU and Cardialysis."
"The alliance between Cardialysis and University Hospitals Case Medical Center matches perfectly with our clients' wish to use the most innovative imaging core laboratory techniques in their global cardiovascular studies. Moreover, the integrated teams will facilitate fast and clear communication through all phases of the study," said Kees Groenhout, CEO of Cardialysis.
Cardialysis is an independent Contract Research Organization (CRO) specializing in cardiovascular disease.